Evidence map›Paper›PMID 28494960›Full record

ArticleBiophysical journal2017

Laser-Activated Polymeric Microcapsules for Ultrasound Imaging and Therapy: In Vitro Feasibility.

Guillaume Lajoinie, Tom van Rooij, Ilya Skachkov, Emilie Blazejewski, Gert Veldhuis, Nico de Jong, Klazina Kooiman, Michel Versluis

Abstract read
In one paragraph

Article in Biophysical journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Guillaume LajoiniePhysics of Fluids Group, MIRA Institute for Biomedical Technology and Technical Medicine and MESA+ Institute for Nanotechnology, University of Twente, Enschede, the Netherlands. Electronic address: g.p.r.lajoinie@utwente.nl.
Tom van RooijBiomedical Engineering, Thoraxcenter, Erasmus MC, Rotterdam, the Netherlands.
Ilya SkachkovBiomedical Engineering, Thoraxcenter, Erasmus MC, Rotterdam, the Netherlands.
Emilie BlazejewskiNanomi B.V., Oldenzaal, the Netherlands.
Gert VeldhuisNanomi B.V., Oldenzaal, the Netherlands.
Nico de JongBiomedical Engineering, Thoraxcenter, Erasmus MC, Rotterdam, the Netherlands.
Klazina KooimanBiomedical Engineering, Thoraxcenter, Erasmus MC, Rotterdam, the Netherlands.
Michel VersluisPhysics of Fluids Group, MIRA Institute for Biomedical Technology and Technical Medicine and MESA+ Institute for Nanotechnology, University of Twente, Enschede, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polymeric microcapsules with a light-absorbing dye incorporated in their shell can generate vapor microbubbles that can be spatiotemporally controlled by pulsed laser irradiation. These contrast agents of 6-8 μm in diameter can circulate through the vasculature, offering possibilities for ultrasound (molecular) imaging and targeted therapies. Here, we study the impact of such vapor bubbles on human endothelial cells in terms of cell poration and cell viability to establish the imaging and therapeutic windows. Two capsule formulations were used: the first one consisted of a high boiling point oil (hexadecane), whereas the second was loaded with a low boiling point oil (perfluoropentane). Poration probability was already 40% for the smallest bubbles that were formed (<7.5 μm diameter), and reached 100% for the larger bubbles. The hexadecane-loaded capsules also produced bubbles while their shell remained intact. These encapsulated bubbles could therefore be used for noninvasive ultrasound imaging after laser activation without inducing any cell damage. The controlled and localized cell destruction achieved by activation of both capsule formulations may provide an innovative approach for specifically inducing cell death in vivo, e.g., for cancer therapy.

Indexed as

Contrast MediaLasersMicrobubblesMolecular ImagingUltrasonographyAlkanesCapsulesCell Membrane PermeabilityCell SurvivalEndothelial CellsFeasibility StudiesFluorocarbonsHumansHuman Umbilical Vein Endothelial CellsLactic AcidPentanesAlkanesCapsulesContrast MediaFluorocarbonsLactic Acidn-hexadecanePentanesperfluoropentanePolyglycolic AcidPolylactic Acid-Polyglycolic Acid CopolymerPolymersPolymethyl Methacrylate

Identifiers

PMID28494960
PMCPMC5425399

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.